文献速递血栓与止血

针对SARS-CoV-2的腺病毒疫苗与mRNA疫苗接种后血小板与适应性及固有免疫细胞的不同交互作用

Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2.
PubMed 文献 · J Thromb Haemost · 2023-03-12

本研究前瞻性纳入健康年轻志愿者,分别接种mRNA疫苗BNT162b2(n=15)或腺病毒疫苗AZD1222(n=25),分析接种前后短期血小板与免疫应答;另在独立队列中回顾性分析阿司匹林对BNT162b2接种后1个月和5个月抗体应答的影响。结果显示两种疫苗抗体应答越快均与血小板聚集物和边缘区样B细胞形成相关,但mRNA疫苗诱导更渐进且耐受性免疫应答并促进血小板与适应性免疫交互,腺病毒疫苗则引发抗病毒样应答伴血小板清除、与B细胞协作减少;服用阿司匹林者(n=56)BNT162b2接种后抗体水平低于匹配个体。作者认为血小板是促进疫苗接种后B细胞应答的固有免疫通路组分。

要点

  • 两种疫苗抗体应答越快均与血小板聚集物和边缘区样B细胞形成相关。
  • mRNA疫苗诱导更渐进、耐受性应答并促进血小板与适应性免疫交互。
  • 腺病毒疫苗引发抗病毒样应答,血小板被清除且与B细胞协作减少。

核心结论

  • 血小板是促进疫苗接种后B细胞应答的固有免疫通路组分。
  • 未来关于免疫后血小板-免疫交互的研究将改善下一代疫苗的安全性、有效性和策略性接种。

研究设计与样本

  • 前瞻性纳入接种mRNA疫苗BNT162b2(n=15)或腺病毒疫苗AZD1222(n=25)的健康年轻志愿者,分析接种前后短期血小板与免疫应答。
  • 另在独立队列中回顾性分析阿司匹林对BNT162b2接种后1个月和5个月抗体应答的影响。

主要发现

  • 对任一种疫苗更快的抗体应答均与血小板聚集物和边缘区样B细胞形成相关。
  • mRNA疫苗与更渐进且耐受性的应答相关,促进血小板与适应性免疫交互。
  • 腺病毒疫苗(两者中免疫原性较弱者)引发抗病毒样应答,血小板被清除且与B细胞协作减少。
  • 服用阿司匹林者(n=56)BNT162b2接种后抗体水平低于匹配个体。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genetic-based COVID-19 vaccines have proved to be highly effective in reducing the risk of hospitalization and death. Because they were first distributed in a large-scale population, the adenoviral-based vaccines were linked to a very rare thrombosis with thrombocytopenia syndrome, and the interplay between platelets and vaccinations increasingly gained attention. OBJECTIVES: The objective of this article was to study the crosstalk between platelets and the vaccine-induced immune response. METHODS: We prospectively enrolled young healthy volunteers who received the mRNA-based vaccine, BNT162b2 (n = 15), or the adenovirus-based vaccine, AZD1222 (n = 25) and studied their short-term platelet and immune response before and after vaccine injections. In a separate cohort, we retrospectively analyzed the effect of aspirin on the antibody response 1 and 5 months after BNT162b2 vaccination. RESULTS: Here, we show that a faster antibody response to either vaccine is associated with the formation of platelet aggregates with marginal zone-like B cells, a subset geared to bridge the temporal gap between innate and adaptive immunities. However, although the mRNA-based vaccine is associated with a more gradual and tolerogenic response that fosters the crosstalk between platelets and adaptive immunity, the adenovirus-based vaccine, the less immunogenic of the 2, evokes an antiviral-like response during which the platelets are cleared and less likely to cooperate with B cells. Moreover, subjects taking aspirin (n = 56) display lower antibody levels after BNT162b2 vaccination compared with matched individuals. CONCLUSION: Platelets are a component of the innate immune pathways that promote the B-cell response after vaccination. Future studies on the platelet-immune crosstalk post-immunization will improve the safety, efficacy, and strategic administration of next-generation vaccines.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Lombardi L, Maiorca F, Marrapodi R, et al. Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2. J Thromb Haemost. 2023. PMID: 36918114. doi:10.1016/j.jtha.2023.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。